Atlas Trials

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Clinical trial NCT03249376 · COMPLETED

Trial details

NCT number
NCT03249376
Sponsor
Intra-Cellular Therapies, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar Depression
Start date
2017-11-27
Primary completion
2019-03-01
Enrollment
381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.